Multicenter HS Study Expanding to More Clinical Sites
Among the objectives of the study, which aims to enroll 8000 patients with HS, is to collect biospecimens from patients for translational studies.
Stay updated with breaking news from Haley Naik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among the objectives of the study, which aims to enroll 8000 patients with HS, is to collect biospecimens from patients for translational studies.
Some populations face longer diagnostic delays for hidradenitis suppurativa (HS), but medical education can help improve knowledge of common dermatologic diseases and reduce delays in diagnosis, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
Some of the many barriers patients with hidradenitis suppurative (HS) face include accessing knowledgeable providers, insurance coverage of treatment, and the way the health care system is set up, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
There are certain considerations when choosing which patient is the best fit for a biologic to treat hidradenitis suppurativa, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.